2023.1 Day 2 VIVA 1
You are currently doing an all-day endoscopy list in the procedure room. The surgeon would like to add an 80 year old male patient to the end of your afternoon list. He was admitted 2 days ago with a partial bowel obstruction from a possible right sided colon cancer and has undergone bowel preparation as best tolerated. He has a background of COPD and has a decreased eGFR.
What specific additional information do you want to obtain prior to proceeding with his case?
Clinical status of partial bowel obstruction
Ongoing symptoms? Pain, distension, nausea, vomiting?
Tolerance of bowel prep (fluid losses, electrolyte imbalances)?
Volume status
BP, HR, orthostatic changes?
Recent fluid balance, urine output?
Any signs of sepsis (fever, tachycardia, raised WCC)?
COPD severity & respiratory function
Baseline dyspnoea? Oxygen requirements?
Recent exacerbations, hospitalisations?
Pulmonary function tests (if available), baseline ABG?
Renal function & risk of contrast-induced nephropathy
eGFR trends, creatinine, electrolyte abnormalities?
Medications affecting renal function (e.g., ACEi, NSAIDs)?
Aspiration risk
Last oral intake?
Gastric distension on exam (NG decompression needed pre-induction?)
Q: Would you proceed with this case in Scenarioville?
Yes, if adequately optimised with appropriate staff, monitoring, and rescue plans.
If septic, haemodynamically unstable, or needs ICU → discuss transfer to tertiary centre.
What are your key anaesthetic concerns for this patient?
Aspiration risk – partial bowel obstruction → RSI needed.
Hypovolaemia – bowel prep & obstruction → cautious induction.
COPD – risk of perioperative hypoventilation, bronchospasm, CO₂ retention.
Renal impairment – avoid nephrotoxic drugs, ensure adequate perfusion.
How would you optimise the patient before induction?
IV fluid resuscitation
Balanced crystalloid (e.g., Hartmann’s or Plasmalyte) 500–1000 mL titrated.
Endpoints: MAP >65 mmHg, HR normalising, improving urine output.
Electrolyte correction (esp. K+, Mg²+, Ca²+).
Preoxygenation for 3-5 mins (consider NIV if COPD with hypercapnia).
Electrolyte Correction: Potassium, bicarbonate, calcium, and magnesium as needed.
Respiratory Support: Optimise bronchodilators, consider CPAP.
NG tube decompression if significant gastric distension.
What is your induction plan?
Aspiration Risk: High risk due to bowel obstruction.
RSI Required: Preoxygenation, consideration of cricoid pressure (not universally applied), avoidance of bag-mask ventilation, suction availability.
Rapid sequence induction (RSI)
Fentanyl 25-50 mcg IV (blunt pressor response, avoid excessive dosing).
Ketamine 0.5-1 mg/kg IV (if haemodynamically unstable) OR
Propofol 0.5-1 mg/kg IV (cautious dosing due to hypotension risk).
Rocuronium 1.2 mg/kg IV (to secure airway rapidly).
Immediate intubation with cricoid pressure (release if difficulty arises).
Fentanyl
25-50 mcg
Blunts response to laryngoscopy, haemodynamic stability.
Ketamine
0.5 mg/kg
Preserves MAP, avoids excessive hypotension.
Propofol
0.5–1 mg/kg
Lower dose to mitigate hypotension.
Etomidate
0.2–0.3 mg/kg
Alternative for cardiovascular stability.
Rocuronium
1.2 mg/kg
RSI muscle relaxation.
Q: How would you maintain anaesthesia?
Low-dose volatile (Sevoflurane) OR TIVA (Propofol infusion) if haemodynamically stable.
Analgesia: Fentanyl or remifentanil infusion (adjust for renal function).
Ventilation strategy for COPD:
Avoid excessive tidal volumes (~6 mL/kg).
Permissive hypercapnia if needed to prevent barotrauma.
Monitor BP closely, use noradrenaline if needed.
Despite your assessment this becomes a difficult airway. Ho do you approach this?
Assess Difficult Airway Predictors: Mallampati score, neck mobility.
Plan for Video Laryngoscopy: Better first-pass success in difficult airways.
Alternative Approach: Awake fibreoptic intubation if airway concerns exist.
Backup Plan: Supraglottic device, emergency surgical airway.
Post-intubation Ventilation: Cautious PEEP, permissive hypercapnia if COPD exacerbation risk.
What intraoperative challenges do you anticipate?
Haemodynamic Instability: Due to hypovolaemia and anaesthetic agents.
Aspiration Risk: Maintain RSI precautions.
Ventilation Difficulties: COPD exacerbation, potential need for bronchodilators.
Electrolyte Management: Monitor potassium, calcium, magnesium, bicarbonate intraoperatively.
How would you monitor this patient intraoperatively?
Standard Monitoring: ECG, NIBP, SpO₂, capnography.
Invasive Monitoring (if needed): Arterial line for continuous BP monitoring.
Neuromuscular Monitoring: Ensure adequate reversal of neuromuscular blockade.
Blood Gas Analysis: Check for metabolic derangements, CO₂ retention.
The patient is agitated in PACU. What are your differential diagnoses?
Hypercapnia: COPD with residual sedation, narcotic accumulation.
Hypotension: Residual anaesthetic effects, unresolved hypovolaemia.
Pain or Delirium: Poorly controlled pain, emergence delirium.
Hypocalcaemia: Possible due to fluid shifts, electrolyte depletion.
Uraemia: If renal dysfunction is present.
How would you systematically assess and manage this agitation?
Airway & Breathing: High-flow O₂, ABG for CO₂ levels, consider CXR.
Circulation: Check BP, fluid status, correct hypovolaemia.
Neurological Status: Exclude stroke, assess for opioid toxicity (naloxone if needed).
Pain Management: Titrate analgesia carefully.
Sedation Strategy: Consider dexmedetomidine for agitation control.
What are your criteria for safe discharge from PACU?
Haemodynamic Stability: BP and HR within acceptable range.
Adequate Oxygenation: SpO₂ >94% on room air or baseline level.
Appropriate Consciousness Level: Responding to commands.
Adequate Pain Control: Comfortably managed with minimal opioids.
No Uncontrolled Agitation or Delirium
What is your postoperative disposition plan?
Monitoring in HDU or High nurse:patient ratio if unstable postoperatively.
Renal Function Follow-Up: Repeat UECs, address any acute kidney injury concerns.
Respiratory Follow-Up: Monitor for COPD exacerbation, ensure bronchodilator therapy.
Electrolyte Reassessment: Check calcium, potassium, bicarbonate postoperatively.
Last updated